February 28, 2015 3:56 PM ET

Healthcare Providers and Services

Company Overview of Speciality European Pharma Limited

Company Overview

Speciality European Pharma Limited acquires, licenses, and distributes pharmaceutical products, medical devices, or diagnostics for the treatment of urology and urogynaecology disorders in the European market. It offers Bulkamid, a urethral bulking agent used in the treatment of stress urinary incontinence; Mitem/Mitocin (mitomycin), a cytotoxic medicine used in the treatment of cancers, including bladder cancer; Regurin XL, Regurin BD, and Uraplex for the treatment of overactive bladder; and Aquamid, an aesthetic injectable volumiser. The company markets its products through a network of distribution partners. Speciality European Pharma Limited was formerly known as Advent Investments Ltd. ...

14 Took’s Court

London,  EC4A 1LB

United Kingdom

Founded in 1996


44 20 7421 7400


44 20 7421 7401

Key Executives for Speciality European Pharma Limited

Chief Executive Officer and Director
Founder and Non Executive Director
Vice President of Operations
Managing Director of Speciality European Pharma for Germany
Managing Director of Contura International A/S
Compensation as of Fiscal Year 2014.

Similar Private Companies By Industry

Company Name Region
Mild Professional Homes Ltd. Europe
Stonehaven Healthcare Ltd Europe
St. Georges Residential Home Europe
Dr. Michael Frain Ltd. Europe
Lombardy Court VCT Ltd Europe

Recent Private Companies Transactions

Private Placement
January 14, 2015

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Rush University United States
Greater Houston Partnership United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Speciality European Pharma Limited, please visit www.specialityeuropeanpharma.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.